Company Filing History:
5 out of 167 
1 out of 822 
Years Active: 2015-2018
Title: Viktor Lakics: Innovator in Pharmaceutical Chemistry
Introduction
Viktor Lakics is a notable inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on tricyclic quinoline and quinoxaline derivatives. With a total of 5 patents to his name, Lakics has established himself as a key figure in the development of new therapeutic agents.
Latest Patents
One of Viktor Lakics' latest patents focuses on tricyclic quinoline and quinoxaline derivatives. This invention relates to a pharmaceutical composition containing these compounds, which serve as modulators, specifically as agonists or partial agonists of the 5-HT receptor. The patent outlines their use in preparing a medicament for the prevention or treatment of conditions and disorders that respond to the modulation of the 5-HT receptor. This innovative approach has the potential to address various medical conditions effectively.
Career Highlights
Throughout his career, Viktor Lakics has worked with prominent companies in the pharmaceutical industry, including AbbVie Deutschland GmbH & Co. KG and AbbVie Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in the field.
Collaborations
Viktor Lakics has collaborated with esteemed colleagues such as Wilfried Martin Braje and Helmut Mack. These partnerships have further enhanced his research capabilities and have led to significant advancements in pharmaceutical innovations.
Conclusion
Viktor Lakics is a distinguished inventor whose work in pharmaceutical chemistry has made a lasting impact. His innovative patents and collaborations highlight his commitment to advancing medical science. His contributions continue to pave the way for new therapeutic solutions.